319 related articles for article (PubMed ID: 20594840)
1. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
Li ZL; Li QS; Zhang HJ; Hu Y; Zhu DD; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4413-20. PubMed ID: 21752655
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
[TBL] [Abstract][Full Text] [Related]
5. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Li HQ; Luo Y; Zhu HL
Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
[TBL] [Abstract][Full Text] [Related]
9. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
[TBL] [Abstract][Full Text] [Related]
11. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Ashek A; Cho SJ
Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH).
Alhamadsheh MM; Waters NC; Huddler DP; Kreishman-Deitrick M; Florova G; Reynolds KA
Bioorg Med Chem Lett; 2007 Feb; 17(4):879-83. PubMed ID: 17189694
[TBL] [Abstract][Full Text] [Related]
14. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
Song H; Ao GZ; Li HQ
Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.
Singh S; Soni LK; Gupta MK; Prabhakar YS; Kaskhedikar SG
Eur J Med Chem; 2008 May; 43(5):1071-80. PubMed ID: 17707951
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.
Song X; Yang Y; Zhao J; Chen Y
Chem Pharm Bull (Tokyo); 2014; 62(11):1110-8. PubMed ID: 25196128
[TBL] [Abstract][Full Text] [Related]
18. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Yang YS; Zhang F; Gao C; Zhang YB; Wang XL; Tang JF; Sun J; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Jul; 22(14):4619-24. PubMed ID: 22721711
[TBL] [Abstract][Full Text] [Related]
19. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
Cheng K; Xue JY; Zhu HL
Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
